Home Health Vanguard summit: Psychiatrist unveils technology option for youth mental health
Health

Vanguard summit: Psychiatrist unveils technology option for youth mental health

Dr Olufemi Olutayo
Dr Olufemi Oluwatayo, Consultant Psychiatrist
Share

By Destiny Obinna

Young Nigerians living with depression, anxiety, obsessive-compulsive disorder, OCD, and post-traumatic stress disorder, PTSD, who do not respond adequately to conventional treatment may have another option in Transcranial Magnetic Stimulation, TMS, a consultant psychiatrist has said.

Dr Olufemi Oluwatayo, Consultant Psychiatrist, Fellow of the Royal College of Psychiatrists, London, and Medical Director, Ikeja Specialist Clinic & TMS Centre, Lagos, will highlight the technology-based treatment at the 4th Vanguard Mental Health Summit, opening Friday, October 9, 2026, at the Civic Centre, Victoria Island, Lagos.

Oluwatayo will speak on “Using Technology to Manage Common Mental Health Conditions in Youths: The Role of Transcranial Magnetic Stimulation Treatment” as part of broader discussions on the role of technology in addressing youth mental health.

The summit is themed “Advancing Youth Mental Health in Nigeria through Access, Action and Advocacy,” with the sub-theme, “Mental Health in a Digital Age: Navigating Social Media, Technology and Wellbeing.”

According to Oluwatayo, depression, anxiety, OCD and PTSD are common among young people but are often unrecognised and may not respond adequately to conventional first-line treatments.

“Depression, anxiety, Obsessive Compulsive disorders and PTSD are common in young people and often go unrecognised. They may not respond to the usual first line treatments, i.e. antidepressants and talking therapy,” he said.

He added that side effects associated with some antidepressants could affect adherence, making alternative treatment options important.

“For these reasons, TMS should be considered as a treatment option,” he said.

Oluwatayo, who is also Chief Executive Officer of Retreat Healthcare, Ikorodu, said young people’s familiarity with technology could make them more receptive to technology-based treatment.

ALSO READ  NAS launches six-month mentorship for 25 young scientists

“Research has shown that it is safe for use in young people just as in adults as it has no lasting side effects,” he said.

TMS is a non-invasive treatment that uses magnetic pulses to stimulate specific areas of the brain.

Explaining the procedure, Oluwatayo said: “A TMS machine produces pulses that are passed through magnetic coils to generate magnetic waves. The magnetic coils are placed on specific parts of the scalp on the head to target certain parts of the brain.

Advertisement

“The waves from the coils induce tiny electric currents in the part of the brain that is targeted. This resets dysfunctional brain patterns associated with those conditions.”

He explained that treatment protocols are tailored to the condition being managed, with the part of the brain targeted, intensity of stimulation and duration of treatment varying according to the condition.

“The part of the brain targeted depends on the condition being treated. The intensity of the waves and the duration of treatment also depends on the condition. Over the past 10 years or so different centres in the US, UK and Australia have developed different protocols for different conditions,” he said.

According to the psychiatrist, two common approaches are the standard and accelerated TMS protocols.

“In the standard protocol, a session lasts for 30 minutes and is given five days a week for six weeks. Whilst the accelerated protocol lasts for only a few minutes and is repeated several times a day over a two weeks period.

ALSO READ  Edo Assembly Speaker advocates better care for arthritis patients

“The overall number of treatments for both protocols is 30 but given over a shorter period in the accelerated protocol,” he added.

On outcomes, Oluwatayo said available research and clinical evidence indicated that TMS could benefit some patients who had not responded to other treatments.

“There are research and clinical evidence that it works in 50 percent of patients who have failed to respond to other treatments,” he said.

He added that the treatment was generally well tolerated, with brief scalp aches and tiredness among the common side effects.

Participants at the Vanguard summit will also have an opportunity to see how the technology works through a video presentation, although there will be no live demonstration.

“It is impossible to do a real life demonstration but I will show a video of how it is used and pictures of the machine at the clinic,” Oluwatayo said.

TMS is currently available at the Ikeja Specialist Clinic, which, according to Oluwatayo, has partnered with a United Kingdom-based company for training and technical support.

His presentation is expected to form part of the summit’s wider examination of how technology can both contribute to mental health challenges and expand access to treatment and support for young people.

Share
Related Articles
Health

NAFDAC dismisses Camosunate ban claim, urges Nigerians to ignore social media alert

By Destiny Obinna The National Agency for Food and Drug Administration and...

Health

PSHAN, WHO, Adesina demand more private investment in Nigeria’s healthcare

By Matthew Johnson The Private Sector Health Alliance of Nigeria (PSHAN), the...

Health

Family physicians propose cluster model to strengthen Nigeria’s failing primary healthcare system

By Destiny Obinna Family physicians have proposed a team-based model for managing...

Health

Nigeria’s PHC system in crisis as 80% of centres fail to function

By Destiny Obinna Nigeria’s primary healthcare system is facing a deepening crisis,...